arrow
R

Rebecca Kondor

us centers for disease control and prevention
H指数:25
被引数:2,903

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza Vaccine Effectiveness Against Outpatient Acute Respiratory Illness With Laboratory-confirmed Influenza, United States, 2024–2025 Season

2024–2025流行季美国实验室确诊流感的门诊急性呼吸道疾病的流感疫苗有效性

2026-07-140
PRE
Next-Generation Sequencing Strategies During the 2024–2025 Avian Influenza A(H5N1) Emergency Response in the U.S

2024–2025年美国禽流感A(H5N1)应急响应期间的下一代测序策略

Viruses
IF3.5
2026-04-220
OAAI
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses

季节性流感病毒遗传变异追踪的命名法

2026-02-130
OAAI
Effects of age and birth cohort on influenza A virus subtype-specific hospitalization rates, United States 2010-2025

年龄和出生队列对美国2010-2025年甲型流感病毒亚型特异性住院率的影响

2026-01-010
PRE
Antiviral susceptibility monitoring: testing algorithm, methods, and findings for influenza season, 2023-2024

抗病毒敏感性监测:2023-2024流感季节的检测算法、方法和结果

2025-10-110
PRE
Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023

2020–2023年流感病毒对神经氨酸酶抑制剂及帽依赖性核酸内切酶抑制剂baloxavir的易感性全球更新

2025-06-240
OA
Influenza Vaccine Effectiveness Against Medically Attended Outpatients Illness, United States, 2023-2024 Season
2025-01-065
OA
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
2024-09-254
OA
Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022-April 2023
2024-06-230
OA
An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution

SARS-CoV-2变异的更新框架反映了病毒进化的不可预测性

2024-05-084
PRE
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves

在整个Delta到Omicron波中,美国循环和新兴SARS-CoV-2变体的抗原表征

2024-05-074
OAAI
Timing of seasonal influenza epidemics for 25 countries in Africa during 2010-19: a retrospective analysis

非洲25个国家2010至19日季节性流感流行的时间: 回顾性分析

2023-05-0110
OAAI
SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States
2022-07-0123
OAAI